Animals were housed under barrier condition with a 12 hour light/dark cycle and access to food and water ad libitum. To generate transgenic mice conditionally expressing dominant negative (dn) E-cadherin, we used a plasmid, obtained from H. Semb, that encodes a 34kDa myc-tagged cell surface protein where 625 amino acid residues from the extracellular domain of E-cadherin have been deleted (Dahl et al., 1996) . The dn E-cadherin c-DNA was isolated as a 1,3kb XbaI -HindIII fragment. The XbaI site was blunted with T4 DNA polymerase.
mice. Line 253 which can be induced up to 1000-fold within 1 week was used for all further experiments ( Figure S3B ). Immunoblotting of lung lysates from bitransgenic mice after 1 week of DOX administration revealed protein expression of dn E-cadherin in vivo ( Figure   S3C ). To test for expression of dn E-cadherin in type II epithelial cells, paraffin embedded lung sections of bitransgenic (SP-C rtTA / Tet-O dn E-cadherin) mice were subjected to immunostaining. SP-C expressing cells stained positive for myc-tagged dn E-cadherin only after treatment with DOX, indicating that induced transgene expression was restricted to type II cells ( Figure S3D ). Double-transgenic offspring were crossed with homozygous tumor mice expressing oncogenic C-RAF BXB in type II pneumocytes (Kerkhoff et al., 2000) to obtain triple transgenic progeny. Genotyping of SP-C rtTA and SP-C C-RAF BXB mice was as described (Kerkhoff et al., 2000; Perl et al., 2002) . For induction of mice, doxycycline HCl (DOX, Sigma Chemical) was diluted in the drinking water to 500 µg/mL. Due to its light sensitivity, the DOX solution was replaced every week and was given in black, light protected bottles (Harlan). Homozygous Cdh 1 flox/flox mice (Boussadia et al., 2002) were first crossed with Tet-O Cre (Schönig et al., 2002) . Double transgenic mice were crossed with a SP-C rtTA ). Detection of Cdh 1 flox allele was as previously described (Boussadia et al., 2002) . The knock-out allele used the primers as follows: sense primer (S2): 5'-CTT CTA CAG GGG ACT TGA GAT -3'; antisense primer (S4): 5'-GTG ACA CAT GCC TTT ACT TTA -3'.
RNA isolation and RT-PCR analysis
After surgery, lung samples were frozen over dry ice in O.C.T. compound and stored at -80°C. 10 µm frozen tissue sections were prepared using a cryostat. Sections were then mounted on membrane coated glass slides (Leica) and stained with Gill's haematoxylin (Sigma Chemical) for 30 seconds and rinsed with water. Slides were air-dried and stored at -80°C. Tumor areas were micro-dissected with a laser beam on a Leica DMLA microscope.
Total RNA was extracted using an RNeasy Micro Kit (Qiagen). Briefly, 35 µl of lysis buffer was used for lysis of micro-dissected tissues. The RNA was eluted in 14 µl of RNase-free water and then quantified by using the ribo green quantitation kit (Molecular Probes)
according to the manufacturer's protocol. One-step RT-PCR was performed according to the manufacturer's specifications (Qiagen) with 250 ng of RNA. The following RT-PCR conditions were used: for ß-actin; 1 cycle of 50°C for 30 min and 1 cycle of 95°C for 15 min followed by; 30 cycles of 94°C for 2 min, 56°C for 40 sec, and 72°C for 1 min; and a final cycle of 72°C for 10 min; for E-cadherin; 1 cycle of 50°C for 30 min and 1 cycle of 95°C for 15 min followed by; 35 cycles of 94°C for 30 sec, 64°C for 30 sec, and 72°C for 1 min; and a final cycle of 72°C for 10 min. Reactions without template RNA were used as a negative control. The RT-PCR for ß-actin was used to check the quality of the RNA extraction and RT-PCR. The primers were as follows: for ß-actin (490 bp): sense primer: 5'-GTC GTA CCA CAG GCA TTG TGA TGG-3'; antisense primer: 5'-GCA ATG CCT GGG TAC ATG GTG G-3' ; For E-cadherin (550 bp): sense primer: 5'-TTG GAC GTC CAT GTG TGT GAC -3';
antisense primer: 5'-GTT GCC CCA CTC GTT CAG ATA-3' . We analyzed 12 µl of PCR products by electrophoresis on a 1.5 % agarose gel. DNA fragments were visualized and photographed under UV light after ethidium bromide staining.
Conditions for RT-PCR analysis of Wnt/ß-catenin responsive genes have been previously described (Okubo and Hogan, 2004; Boerboom et al., 2006) . For detection of VEGF genes of the mouse 3041 (Rizzino et al., 1982) and human A 549 lung tumor cells, RNAs were isolated using trizol-based extraction, converted to cDNA and analysed by quantitative RT-PCR employing mouse primers as described in Table S1 . Conditions of human VEGF mRNAs were as described before (Abraham et al., 2000) .
Quantitative RT-PCR analysis of lung tissues from acutely (36 hours) induced triple transgenic mice was performed using the genes and conditions listed in Table S1 . RNA from total lung was extracted with Bio Robot EZ1 technology (Qiagen) according to the manufacturer's description. 1 µg RNA was reverse transcribed using first strand cDNA synthesis kit by following the manufacturer's protocol (K 1612, Fermentas) . 2 µl (50 ng) from the resulting cDNA and 0.5 µM of each gene-specific forward or reverse primer (for primers and sequences, see Table S1 ) was used for amplification with SYBR green PCR master mix (F-410S/L, DyNAmo HS SYBR Green qPCR Kit). As an internal control, the mRNA for the microglobulin gene (Micro) and GAPDH (in case of human material) was used. 
Immunoblotting, Immunoprecipitation
To detect tumour specific endogenous E-cadherin and ß-catenin proteins, we used isolated pure type II cells from four months old induced and control triple transgenic mice as described (Rice et al., 2002) . Cells were lysed in ice cold lyses buffer (10 mM Tris-HCl, pH 7.4, 1 % Triton X-100, 0.4 % deoxycholate, 66 mM EDTA with protease inhibitor cocktail)
by careful sonication. The homogenates were centrifuged at 11,000 rpm for 10 minutes.
Supernatants from samples in lysis buffer were analysed for protein concentration (based on Bradford protein assay). Samples were solubilized with an equal volume of loading buffer (125 mM Tris-HCl, pH 6.8, 4 % sodium dodecyl sulfate, 20 % glycerol, 0.05 % bromophenol blue, 5 % ß-mercaptoethanol) and were boiled for 3 min. The samples were then separated by SDS-PAGE, transferred to nitrocellulose membranes and detected by immunoblotting with primary antibodies against ß-catenin (clone 14, BD Transduction Lab), and rat anti E-cadherin antibodies (clone ECCD-2, Zymed Lab) respectively. After three washes with TBST buffer, the membrane was incubated with anti-mouse IgG and anti Rat IgG horseradish peroxidase conjugates (Amersham Pharmacia Biotech) for 60 min and visualized with ECL detection kit.
For the analysis of dn E-cadherin expression, anti-c-Myc mouse monoclonal antibody (Santa Cruz sc-40, clone 9E10) was used as previously described (Dahl et al., 1996) . As an internal control, a rabbit antibody to GAPDH (ab9485, Abcam Ltd) was used. For N-cadherin expression, tumour cells and CD31 positive endothelial fraction were isolated (Rice et al., 2002) , homogenized in RIPA buffer containing protease inhibitor cocktail and subjected to
Western blot by using mouse anti N-cadherin (clone 3B9, Zymed Lab.) antibody. Attached CD31 positive endothelial fraction served as positive control for N-cadherin expression.
Alpha actin was the internal control (A 2066, Sigma). Antibodies were used according to the conditions recommended by the manufacturer. Detection of P-cadherin expression from total lung of four months DOX treated mice was performed using rat anti-P-cadherin (Clone PCD-1, Zymed, Invitrogen). Alpha actin was the internal control (A 2066, Sigma). Antibodies were used according to the conditions recommended by the manufacturer.
Histopathology and Immunofluoresence Microscopy
Animals were sacrificed and lungs were fixed under 25 cm water pressure with 4 % PBS buffered formalin. Histology was done on formalin-fixed, paraffin-embedded lung specimen.
6 µm-cut sections were deparaffinized, rehydrated in graded alcohols and haematoxylin-eosin stained. To quantitate membrane E-cadherin and nuclear ß-catenin expression in tumors, ten random intratumoral areas (± 200 cells / area) for each of 5 mice were evaluated using specific immunohistochemistry. Intratumoral vessel density was evaluated as previously described (Gasparini et al., 1994) with some minor modifications. For CD31 staining, at least, 10 tumours were analysed per mouse. Five randomly selected intratumoural fields (100 x 100 µm) were counted per tumor.
Quantification of intratumoral lymphatic vessel density was assessed using two different markers (LYVE-1 and Prox1) in the same way. For determination of vessel diameter of the counted vessels, we used a microscope software based scaling technique (Leica DMLA).
For determination of the localisation of myc-tagged dn E-cadherin, bitransgenic mice were sacrificed, the lungs were isolated and paraffin embedded. In order to mark alveolar type II cells and dn-E-cadherin expression, a double immunofluorescence staining was performed using a rabbit antibody against pro-SPC (1:5000, a gift from J. Whitsett) and an anti-c-myc mouse monoclonal antibody (1:200, clone 9E10, Santa Cruz, USA), respectively. Donkey anti-rabbit Alexa FluorChemicon Int., USA) secondary antibodies were applied for detection. Antibody (gp84) used for E-cadherin detection in paraffin sections was a gift from R. Kemler. Immunofluorescence staining to detect endogenous E-cadherin employed frozen sections and an anti-mouse Ecadherin mouse monoclonal antibody (Zymed Laboratories, clone ECCD2) as described (Perl et al., 1999) . Immunohistochemical staining with monoclonal rat anti-mouse CD31 antibody (clone MEC 13.3, BD Pharmingen) was performed as previously described (Zeng et al., 1998 (ns=non significant; *P<0.05; **P<0.01; *** P <0.001). Epithelial mouse lung 3041 were transfected with empty plasmid or SP-C rtTA/tetO dn Ecadherin plasmids and stained for ß-catenin (green). Note relocation of ß-catenin in the cytoplasm.
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